Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotika och kemoterapeutiska medel för dermatologisk användning - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

mylan ire healthcare limited - fondaparinuxnatrium - venous thrombosis; pulmonary embolism; myocardial infarction; angina, unstable - antitrombotiska medel - 5-mg / 0. 3 ml och 2. 5-mg / 0. 5-ml solution for injectionprevention of venous thromboembolic events (vte) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee surgery or hip-replacement surgery. förebyggande av vte hos vuxna som genomgår kirurgi i buken som bedöms ha hög risk för tromboemboliska komplikationer, till exempel patienter som genomgår buk cancer kirurgi. förebyggande av vte i vuxen medicinska patienter som bedöms ha hög risk för vte och som förvaras på grund av akut sjukdom såsom hjärt-insufficiens och / eller akuta sjukdomar i luftvägarna, och / eller akuta infektiösa eller inflammatoriska sjukdomar. behandling av vuxna med akut symtomatisk spontana ytliga ventrombos i nedre extremiteterna utan samtidig djup ventrombos. 5-mg / 0. 5-ml solution for injectiontreatment of unstable angina or non-st-segment-elevation myocardial infarction (ua/nstemi) in adult patients for whom urgent (< 120 mins) invasive management (pci) is not indicated. infarkt (stemi) hos vuxna patienter som lyckats med trombolytika eller som inledningsvis är att få någon annan form av terapi reperfusion. 5-mg / 0. 4 ml, 7. 5-mg / 0. 6 ml och 10 mg/0. 8-ml solution for injectiontreatment of adults with acute deep-vein thrombosis (dvt) and treatment of acute pulmonary embolism (pe), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - nelarabin - prekursor t-cell lymfoblastisk leukemi-lymfom - antineoplastiska medel - nelarabine är indicerat för behandling av patienter med t-cell akut lymfatisk leukemi (t-all) och t-cell lymfatisk lymfom (t-lbl) vars sjukdom inte svarat på eller har återfall efter behandling med minst två cytostatika kurer. due to the small patient populations in these disease settings, the information to support these indications is based on limited data.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

n.v. organon - desloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminer för systemiskt bruk, - azomyr is indicated for the relief of symptoms associated with:allergic rhinitis (see section 5. 1)urticaria (see section 5.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - läkemedel mot obstruktiv lungsjukdom, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol - astma - läkemedel mot obstruktiv lungsjukdom, - budesonid / formoterol teva pharma b. indikeras endast hos vuxna 18 år och äldre. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastiska medel - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika för systemisk användning - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

laboratoires delbert - histamin dihydrochloride - leukemi, myeloid, akut - immunstimulatorer, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). effekten av ceplene har inte visats fullständigt hos patienter som är äldre än 60 år.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - pemetrexed dinatriumhemipentahydrat - carcinoma, non-small-cell lung; mesothelioma - antineoplastiska medel - malignant pleural mesothelioma ciambra in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancer ciambra in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. ciambra är indicerat som monoterapi för underhåll behandling av lokalt avancerad eller metastaserad icke-småcellig lungcancer andra än huvudsakligen skivepitelcancer histologi hos patienter vars sjukdom inte har gått omedelbart efter platinum-baserad kemoterapi. ciambra är indicerat som monoterapi för andra linjens behandling av patienter med lokalt avancerad eller metastaserad icke-småcellig lungcancer andra än huvudsakligen skivepitelcancer histologi.